PS Ratio: 9.60

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 9.60 is 45% below its estimated 2-year average of 17.54, near the low end of its estimated 2-year range (6.62–43.21).

As of 2026-10-06T19:07:54.042Z. 49.83% below its estimated 12-month average of 19.14.

PRLD PS Ratio Metrics

P/S vs. estimated history

At 9.60, P/S is below its estimated 2-year median — higher than 16% of readings in its estimated 2-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Prelude Therapeutics Incorporated (PRLD)?

The P/S ratio for PRLD stock is 9.60.

Is Prelude Therapeutics Incorporated's P/S ratio high or low?

The P/S ratio of 9.60 is 45% below its estimated 2-year average of 17.54, near the low end of its estimated 2-year range (6.62–43.21).

What is the estimated TTM average P/S ratio for Prelude Therapeutics Incorporated (PRLD)?

The estimated TTM average P/S ratio for PRLD stock is 19.14.

Showing the most recent 260 of 477 data points. The chart above shows the full history.

Related Metrics